Estrogen's potential impact on chemoresistance in high-grade serous ovarian cancer

被引：0
|
作者：
Marolt, N. [1 ]
Pavlic, R. [1 ]
Gjorgoska, M. [1 ]
Kreft, T. [1 ]
Rizner, T. Lanisnik [1 ]
机构：
[1] Univ Ljubljana, Fac Med, SI-1000 Ljubljana, Slovenia
来源：
FEBS OPEN BIO | 2024年 / 14卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-26-081
引用
收藏
页码：283 / 283
页数：1
相关论文
共 50 条
  • [41] Defining the Molecular Footsteps of High-Grade Serous Ovarian Cancer
    Nagendra, P.
    Lombard, J.
    Jamaluddin, F.
    Tanwar, P.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 26 - 26
  • [42] Principles of dormancy evident in high-grade serous ovarian cancer
    Shepherd, Trevor G.
    Dick, Frederick A.
    CELL DIVISION, 2022, 17 (01)
  • [43] Targeting estrogen metabolism in high-grade serous ovarian cancer shows promise to overcome platinum resistance
    Marolt, Nika
    Pavlic, Renata
    Kreft, Tinkara
    Gjogorska, Marija
    Rizner, Tea Lanisnik
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 177
  • [44] Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma
    E. T. Taube
    C. Denkert
    K. Pietzner
    M. Dietel
    J. Sehouli
    S. Darb-Esfahani
    Virchows Archiv, 2015, 466 : 333 - 342
  • [45] Prognostic impact of neuroendocrine differentiation in high-grade serous ovarian carcinoma
    Taube, E. T.
    Denkert, C.
    Pietzner, K.
    Dietel, M.
    Sehouli, J.
    Darb-Esfahani, S.
    VIRCHOWS ARCHIV, 2015, 466 (03) : 333 - 342
  • [46] Diagnostic potential for serum piR-8111406 for detection of high-grade serous ovarian cancer
    Wu, Y.
    Cui, W.
    CLINICA CHIMICA ACTA, 2024, 558 : 55 - 55
  • [47] MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer
    Baath, Maria
    Jonsson, Jenny-Maria
    Fremer, Sofia Westbom
    de la Fuente, Laura Martin
    Tran, Lena
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Honeth, Gabriella
    Hedenfalk, Ingrid
    GENES, 2021, 12 (05)
  • [48] The metastatic potential of high-grade serous ovarian cancer cells along disease progression.
    Ritch, Sabrina J.
    Goyeneche, Alicia A.
    Noman, Abu S.
    Telleria, Carlos M.
    CANCER RESEARCH, 2021, 81 (13)
  • [49] Longitudinal spatial profiling reveals chemoresistance mechanisms and characteristics of minimal residual disease in high-grade serous ovarian cancer
    Dai, Yibo
    Knisely, Anne
    Lawson, Barrett Craig
    Lee, Sanghoon
    Wani, Khalida M.
    Segura, Rossana N. Lazcano
    Melendez, Brenda
    Chen, Jianfeng
    Liu, Yunhe
    Chelvanambi, Manoj
    Gibson, Laura A.
    Johnson, Sarah B.
    Yeh, Chih-Chen
    Ingram, Davis R.
    Hudgens, Courtney W.
    Cho, Kyung Serk
    Pei, Guangsheng
    Jiang, Jiahui
    Chu, Yanshuo
    Lazar, Alexander J.
    Gao, Jianjun
    Wargo, Jennifer
    Wang, Linghua
    Jazaeri, Amir A.
    CANCER RESEARCH, 2024, 84 (06)
  • [50] High-grade serous ovarian cancer (HGSOC) with fallopian tube involvement
    Tanase, Adina Elena
    Solomon-condriuc, Iustina Petra
    Mogos, Raluca Anamaria
    Costachescu, Gabriel
    David, Cristina
    Buzduga, Catalin Mihai
    Scripcariu, Dragos Viorel
    Costea, Claudia Florida
    Cucu, Andrei Ionut
    Tanase, Gabriel Valentin
    Tanase, Daniela Maria
    Nemescu, Dragos
    Dumitrescu, Ana Maria
    Carauleanu, Alexandru
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2024, 65 (02): : 325 - 329
12345